Novo Nordisk’s recovery hits the level that broke the stock: $47 decides
The post Novo Nordisk’s recovery hits the level that broke the stock: $47 decides appeared on BitcoinEthereumNews.com. The chart on Novo Nordisk A/S (NVO) is back at the line that ended last year’s rally. Price has run from the early-April low at $35.10 to $46.90 today, up 1.29% on roughly 14.25 million shares, and is now pressing into the $47 horizontal resistance that has capped this stock since the winter breakdown. Novo Nordisk reported Q1 2026 results in early May showing adjusted sales down 4% at constant currencies, but the market shrugged it off. Shares rose on the report, and the stock has been recovering since. The recovery has done the easy part. Clearing $47 is what makes it a trend. Look at where $47 came from. Through late summer and into the fall of 2025, $47 was the level price kept defending. Every pullback into that zone got bought, every bounce launched off it, and the stock used it as the floor for the back half of the year. Then the early-2026 collapse blew through